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Key Points 
- Surgery is an effective treatment for DCM. 
- Age is correlated with functional outcomes and the risk of perioperative morbidity 
following surgery for DCM, but it is a non-modifiable risk factor. 
- Cardiovascular co-morbidity, diabetes, and obesity are all associated with reduced 
functional improvement following surgery for DCM. 
- Many co-morbidities can increase the risk of perioperative complication. 
 
 
Synopsis 
Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal 
cord injury worldwide.  Even relatively mild impairment in functional scores can significantly 
impact daily activities.  Surgery is an effective treatment for DCM, but outcomes are dependent 
on more than technique and preoperative neurologic deficits. 
 
Introduction 
Degenerative cervical myelopathy (DCM) encompasses multiple degenerative conditions 
including cervical spondylotic myelopathy (CSM), ossification of the posterior longitudinal 
ligament (OPLL), ossification of the ligamentum flavum (OLF), and degenerative disc disease.1  
Forms of degenerative myelopathy are the most common cause of non-traumatic spinal cord 
injury in the aging population.2,3  While the natural history of DCM is unclear,4 Fehlings and 
Arvin documented an important clinical observation that even clinically stable, mild myelopathy 
can be associated with significant functional limitations.5  Prospective data from AO North 
American and International cohorts of patients with cervical myelopathy have demonstrated 
that surgery provides a significant functional benefit, significantly improves quality of life, and is 
cost-effective.6–8  Age, medical comorbidities, and smoking status are associated with functional 
outcomes following surgery.9–11  Achieving a positive outcome relies on understanding how 
these factors influence patient selection, surgical decision making, and functional improvement. 
 
Age 
Approximately 90% of patients over age 65 will have some evidence of cervical spondylosis on 
imaging studies.12  However,  the existence of degenerative changes or spinal cord compression 
on imaging does not necessarily correlate with symptoms of myelopathy.13,14 Degenerative 
changes will continue to progress over time15 and may result in the development of functional 
deficits.  Bednarik, et al. prospectively followed asymptomatic patients with cervical 
spondylosis and observed the development of myelopathy in more than 22% of patients within 
a median follow-up time of 44 months.14  Thus, as the average age of the general population 
and life expectancy both increase, it is likely that the number of people with degenerative 
cervical myelopathy will also climb.   
 
Prospectively collected data has shown that surgery provides a significant clinical benefit for 
patients with cervical myelopathy,6,7,16 but how does age impact outcomes?  Data from the 
international arm of the AOSpine CSM study found preoperative modified Japanese Orthopedic 
Association (mJOA) scores were significantly lower and preoperative Nurick scores were 
significantly higher in elderly patients (aged 65 or older) when compared with the younger 
cohort.10  Post-operatively, elderly and non-elderly patients were found to have a significant 
improvement in Nurick and mJOA scores following surgery, however younger patients still had 
significantly higher mJOA and lower Nurick scores (Table 1).10  Tetreault et al. used combined 
data from the AOSpine CSM-International and CSM-North American studies to construct 
prediction models for the minimum clinically important difference (MCID) in mJOA score after 
surgery for cervical myelopathy; MCID was defined as a 1 point improvement for mild, 2 points 
for moderate, and 3 points for severe myelopathy.17  Younger age was found to be a significant 
predictor of achieving the MCID on post-operative mJOA score; for every 10-year increase in 
age, a patient was 8-9% less likely to achieve the MCID.9,11  A separate prospective study by 
Machino et al. also concluded that patient age of 65 or older was a significant risk factor for 
lower preoperative and postoperative JOA score and lower JOA recovery rate.16,18 
 
Data from larger retrospective articles concurs with the findings from the prospective AOSpine 
and Machino studies.19,20  A meta-analysis from Madhavan et al. looked at more than 2,800 
patients from 18 different studies, calculated the average age for elderly and non-elderly 
patients, and compared preoperative and post-operative outcomes.  Average age for elderly 
patients was 74, non-elderly average age was 55, and the authors concluded that elderly 
patients had significantly lower preoperative and post-operative JOA scores compared with 
non-elderly, leading to a significantly lower recovery rate.19  A systematic review by Tetreault et 
al. identified 36 articles that examined the impact of age on surgical outcome and then 
categorized them as ‘Excellent,’ ‘Good,’ or ‘Poor’ using a modified version of the SIGN scoring 
system.20  Sixteen articles were identified as ‘Excellent’ and collectively suggested that age may 
be a predictor of outcome using JOA, mJOA, or Nurick scores.20  However, when ‘Good’ and 
even ‘Poor’ articles were included in their assessment, age was not found to be a significant 
predictor of outcome.20   
 
In addition to functional outcomes, there are also significant age-related differences in surgical 
approach.  Sixty-five percent of younger patients (age <65) in the AOSpine CSM-International 
study had anterior surgery while 59% of elderly patients (age ≥ 65)  had posterior surgery.10  Of 
the elderly patients treated anteriorly, a significantly higher percentage had a combined 
discectomy and corpectomy when compared with younger patients (28% vs 13%).10  Elderly 
patients also had more levels decompressed than younger patients, most likely a result of the 
increasing degenerative changes that accumulate with age thus explaining the bias towards 
posterior surgery.10,15  Age-related differences in functional outcomes remained significant 
after controlling for differences in surgical approach.10 
 
While the evidence supports a significant interaction between age and functional improvement 
after surgery for DCM, it is also important to consider the impact of age on post-operative 
recovery and the rate of surgical complication.  Older patients have been found to have 
significantly longer hospital stays,10,19,21 but similar operative time and less blood loss.10,18,19  
Data regarding the relationship between age and complication rate is mixed.  Results from the 
AOSpine CSM-International study and Machino’s cohort did not find any significant difference 
in perioperative complication rate with regards to age.10,18,22  Madhavan’s meta-analysis made 
similar conclusions except that older patients had a higher rate of perioperative delirium.19  
However, a retrospective review of more than 54,000 patients from the Nationwide Inpatient 
Sample (NIS) who underwent surgery for cervical myelopathy found that patients over age 65 
had a significantly higher risk for perioperative complications including cardiac, respiratory, 
gastrointestinal, and wound healing.21,23 
 
Age is a non-modifiable risk factor; it’s impact on functional recovery and perioperative 
complication should be an important part of any preoperative consultation, but it cannot be 
adjusted.  Although age is a fixed predictor, it has also been shown to correlate with the 
incidence and severity of preoperative co-morbidities.10,18,21  Increasing co-morbid score has 
been shown to be a negative predictor for achieving the MCID in functional scores9 and the 
presence of some co-morbidities increases the risk of perioperative complication following 
surgery for cervical myelopathy (Tables 2 and 3).22  Identifying and optimizing modifiable co-
morbidities should be a priority in the preoperative setting in order to maximize outcomes. 
 
 Medical comorbidities 
Cardiovascular 
Cardiovascular comorbidity was the most common comorbidity among enrollees in the 
combined cohorts of the prospective AOSpine CSM study, occurring in 45% of patients.9  
Specific comorbidities included: history of myocardial infarct, congestive heart failure, 
arrhythmia, hypertension, and peripheral vascular disease.22  Functional outcomes analysis 
found cardiovascular comorbidity to be a significant predictor for not obtaining the MCID 
following surgery.9,11  Maeno, et al. retrospectively reviewed their patients with cervical 
myelopathy who had undergone laminoplasty and also found that patients with hypertension 
had significantly lower preoperative and postoperative JOA scores, leading to a lower recovery 
rate.24  
 
A retrospective analysis of patients with symptomatic cervical stenosis looked at the correlation 
between hypertension, MRI findings, and functional scores.25  All patients with a diagnosis of 
hypertension, either controlled or uncontrolled, were significantly more likely to have increased 
signal intensity (ISI) on sagittal T2-weighted MRI when compared with non-hypertensive 
patients and the ISI surface area was significantly larger in hypertensive patients than non-
hypertensive.25  When looking at controlled versus uncontrolled hypertensive patients, the 
surface area of ISI in uncontrolled hypertensive patients was significantly larger than those with 
adequately controlled blood pressure; maximal canal stenosis was equivalent between all 
groups.25  The presence of signal changes in the spinal cord were found to correlate with worse 
mJOA and Nurick scores independent of the surface area of ISI.25 
 
Patients with cardiovascular comorbidity in the CSM-International study, in addition to worse 
functional outcomes, were also significantly more likely to have post-operative complications, 
with hypertension carrying the greatest risk.22  Retrospective review of more than 54,000 
patients from the NIS database found that congestive heart failure (CHF), peripheral vascular 
disorders, and cardiac valvular disease were also associated with a significantly increased risk of 
perioperative complication.23  However hypertension (grouped as complicated and 
uncomplicated) had no impact on perioperative morbidity, but was associated with a decreased 
risk of mortality.23  The authors of this review surmised that a known diagnosis of hypertension 
lead to better preoperative optimization of patients, yielding the observed mortality benefit.23 
 
Cardiovascular co-morbidities have been shown to correlate with perioperative complications 
and functional outcome following surgery for CSM.  While the interaction between 
hypertension and perioperative morbidity is unclear, hypertension may significantly compound 
the neurological damage caused by cervical spondylosis.  The impact of cardiovascular co-
morbidities on outcomes should be discussed with the patient and optimized prior to elective 
surgery to minimize the risk of perioperative complication and maximize the chances for 
functional improvement. 
 
Diabetes 
The rate of diabetes among patients undergoing surgery for DCM is cited at 9-36%, making it 
the second most common co-morbidity in this population.26–30  Although chronic diabetes is 
known to have neurological sequelae, data regarding preoperative functional scores in diabetic 
patients with DCM is mixed: retrospective data from a few small studies suggests that diabetic 
patients do not have significantly worse preoperative JOA24,27,28,31 or Nurick scores.32  However, 
one prospective study found diabetic patients had a significantly higher preoperative Nurick 
score, but no difference in mJOA26 while another study observed significantly lower 
preoperative JOA scores in diabetic patients compared with non-diabetic patients.29  Regardless 
of preoperative differences, diabetic patients appear to have a significant improvement in 
functional scores after surgery.26–28  Some studies have found total post-operative JOA, mJOA, 
and Nurick scores to be significantly worse among diabetic versus non-diabetic patients26,29,32  
while others have found significantly less recovery of only lower extremity motor and sensory 
function based on JOA score.27,31  Despite these differences, univariate analysis from the 
AOSpine CSM studies found that endocrine co-morbidities did not significantly impact 
realization of an MCID on the mJOA scale.9,11  While individual diagnoses within the endocrine 
category were not evaluated, diabetes undoubtedly constituted a significant component.   
 
The impact of diabetes on outcomes following surgery for DCM has also been evaluated based 
on hemoglobin A1c (HbA1c) and serum blood glucose levels.  Preoperative HbA1c levels in 
diabetic patients with DCM ranged from 6.5-8.3%16,27,31 and were found to negatively correlate 
with post-operative JOA recovery rate (Table 4).29,31  One retrospective study found higher 
average perioperative glucose values in diabetic patients negatively correlated with 
improvement in Nurick score; stratification using an average blood glucose cut-off of 150 mg/dL 
found significantly improved outcomes for diabetic patients with values below 150.32  While 
absolute values make it easier to monitor and adjust perioperative care, two other studies, one 
prospective and one retrospective, observed no correlation between either fasting blood 
glucose levels or highest perioperative blood glucose level and JOA recovery rate.16,31  Duration 
of diabetes may also be important as one prospective study observed patients who had 
diabetes for more than 10 years had a lower JOA recovery rate following surgery.16  Kawaguchi, 
et al. did not find a similar association, but their conclusion was based on an average duration 
of diabetes of 6.7 years.31 
 
In addition to functional recovery, it is also important to consider how diabetes impacts the 
perioperative process.  Diabetes is not associated with significantly increased length of surgery 
or greater blood loss when compared with non-diabetic patients.29,31  While some studies have 
found no difference in major surgical complication rates between diabetic and non-diabetic 
patients,26,27,29,31 larger data sets have suggested that diabetic patients do have a significantly 
increased risk of perioperative complications including: respiratory complications, cardiac and 
peripheral vascular complications, dysphagia, dysphonia and an increased transfusion 
requirement.22,23,30  Importantly, most studies agree that while diabetic patients may 
sometimes have delayed superficial wound healing, there was no significant difference in the 
rate of surgical site infection.22,30  When comparing well-controlled with poorly-controlled 
diabetic patients, those with poor control were found to have a significantly higher risk of 
perioperative mortality, cardiac complication, hematoma formation, infection, and non-routine 
discharge, but still no difference in the rate of wound complication.30  Cook’s review of the NIS 
database also found that diabetic patients were more likely to have longer hospital stays and 
higher hospitalization costs.30  
  
Although diabetes does not preclude a patient from gaining meaningful functional recovery 
following surgery for DCM, it does appear to limit the extent of recovery and is associated with 
a higher risk of perioperative complication when compared with non-diabetic patients.  Patients 
with a prolonged history of poorly controlled diabetes are the least likely to gain significant 
functional recovery and the most likely to suffer from perioperative complications.  
Furthermore, diabetic patients are also more likely to have general cardiovascular co-
morbidities,26 including hypertension,29 and tend to be older than non-diabetic patients.10,26  
Preparing for positive outcomes in the diabetic patient must go beyond controlling HbA1c and 
blood glucose to identify other conditions that can impact improvement and recovery. 
 
Psychiatric: Depression and Bipolar 
Psychiatric co-morbidity, including depression and bipolar disorder, is observed in 14-25% of 
patients with DCM.11,33  Data analyzing the impact of psychiatric co-morbidities on the 
management of patients with CSM is in limited supply.  The AOSpine CSM-International study 
observed that patients with depression or bipolar had significantly worse preoperative neck 
disability index (NDI) scores compared with those who did not, but mJOA and Nurick scores 
were not significantly different.33  Post-operatively, patients had statistically significant 
improvement in mJOA, Nurick, and NDI scores and while improvement in mJOA and Nurick 
scores were similar between patients with depression and those without, changes in NDI were 
significantly larger in patients without psychiatric disorders.33  Univariate analysis confirmed 
that psychiatric co-morbidities were not significantly correlated with achieving a post-operative 
MCID in mJOA score.11  Zong, et al. also prospectively looked at the impact of depression in 
CSM patients.34  Where the AOSpine study relied on patient reported and clinical review of 
medical records to diagnose psychiatric co-morbidity, Zong obtained Beck Depression Index 
(BDI) scores for a group of 511 patients; patients with a BDI score of 10 or higher were 
considered to have depression.  They found that patients with depression had significantly less 
change in mJOA following surgery, however their final analysis excluded all patients who had 
recovered from their depression or had subsequently become depressed following surgery.34  
 
Evaluation of the impact of psychiatric co-morbidity on functional outcomes is limited by the 
volume and quality of data.  While there does not appear to be an interaction with functional 
outcome, no study has compared outcomes between well-controlled and poorly controlled 
patients, or considered the duration of depression in their evaluation.  Although data from the 
AOSpine CSM-International study found that psychiatric co-morbidities were not a predictor for 
increased risk of perioperative complication,22  they have been shown to correlate with a higher 
incidence of cardiovascular disease.33  Thus preoperative evaluation of the DCM patient with 
psychiatric co-morbidity should take this into account and include adequate screening and 
optimization as necessary given the impact of cardiovascular co-morbidity as outlined above. 
 
Body Mass Index (BMI) 
Of the more than 700 patients enrolled in the AOSpine CSM-North American and International 
studies, 25% were found to be obese (BMI>30 kg/m2), with an additional 36% classified as 
overweight (BMI>24.99 kg/m2).35  At baseline, elevated BMI was correlated with an increased 
NDI but not associated with mJOA; similar observations were made 1 year after surgery.35  
Categorization of outcomes based on weight class found post-operative NDI was an average of 
4.2 points higher in overweight patients and 7.6 points higher in obese patients when 
compared with normal weight patients; only obese patients exhibited a significant difference in 
NDI.35  The likelihood of obese patients achieving the MCID for NDI scores at 1 year was also 
significantly less than for normal weight patients.35  A prospective study by Machino et al. 
utilized JOA scores and also observed that patients with a BMI of 25 kg/m2 or higher did not 
have a significantly increased risk for poor functional outcome, but they did not separately 
evaluate the obese population.16,29 
 
Outside of functional improvement, it’s also important to consider the impact of body weight 
on the perioperative process.  The average BMI of patients in AOSpine CSM-International study 
was 25.8, falling into the ‘overweight’ category; univariate analysis of this population found that 
despite the elevated BMI, there was no increased risk of perioperative complication.22 
Retrospective review of more than 54,000 patients from the NIS database found that obese 
patients had a significantly higher risk of perioperative complication, although they also had a 
lower perioperative mortality.23 
 
While BMI may not directly influence functional outcomes, the obese patient’s perception of 
how their daily activities are impacted by DCM is significantly worse than the non-obese 
patient.  Additionally, obesity was shown to significantly increase the risk of perioperative 
morbidity.  Bodyweight may be a modifiable risk factor that, when optimized, can improve 
patient perceived outcomes and reduce perioperative complications.  
 
Tobacco use 
Data from the combined AOSpine CSM-North American and International studies found that 
27% of enrolled patients were smokers.36  Although smokers tended to be younger than non-
smokers, smokers had significantly less improvement in mJOA and NDI scores 1 year after 
surgery.36  A separate, retrospective study observed smokers to have significantly less 
improvement in Nurick scores and found a significant negative correlation between number of 
packs smoked per day and post-operative change in Nurick score.37  Further analysis of the 
AOSpine cohorts confirmed that smoking status was a significant predictor for achieving an 
MCID on the mJOA 2 years after surgery and the likelihood of having an MCID decreased by 
16% if patient is a smoker.9  Tobacco use was not found to be associated with a higher rate of 
perioperative complication.22 
 
Smoking is a modifiable risk factor that can significantly impact patient outcomes.  The non-
smoker has a significantly higher chance of gaining significant functional recovery following 
surgery.  Tobacco use was also found to interact with other co-morbidities that influence 
outcomes including diabetes and older age; in combination, the chance of poor outcomes is 
further increased.28  Smoking cessation should be a preoperative priority in the patient with 
DCM. 
 
Conclusions 
Degenerative cervical myelopathy is the most common cause of non-traumatic spinal cord 
injury in adults.3  Surgery has been shown to be a safe treatment option that offers significant 
functional improvement, is cost-effective, and improves patient quality of life.6–8,18  However, 
successful outcomes depend on adequate patient counseling and effective management of 
modifiable risk factors.  While age is a not a modifiable risk factor, older patients are more likely 
to have medical co-morbidities; taking the time to look for cardiovascular, endocrine, and 
psychiatric conditions in this population can improve functional recovery and limit 
perioperative complications.  Additionally, weight loss in the obese patient and smoking 
cessation in the tobacco user can also improve outcomes.  Surgery is a valuable therapy for the 
treatment of DCM, but that value relies on proactively identifying obstacles and minimizing 
their impact. 
 
 
 
 
 
 
 
  
 
Outcome Measure Younger 
Patients (<65) 
Elderly Patients 
(≥65) 
p Value 
Baseline    
mJOA 12.86 11.41 <0.0001 
Nurick 3.16 3.75 <0.0001 
24-month post-op    
mJOA 15.45 14.08 <0.0001 
Nurick 1.64 2.44 <0.0001 
Table 1: Preoperative and 24-month post-operative mJOA and Nurick scores compared 
between elderly and non-elderly patients.  Data from Nakashima et al. 2016.10 
 
Clinical Predictor Odds Ratio 95% CI p Value 
Comorbidities 2.03 1.18-3.47 0.01 
Number of co-
morbidities 
1.32 1.11-1.56 0.002 
Comorbidity score 1.19 1.05-1.34 0.006 
Cardiovascular 1.64 1.01-2.68 0.046 
Diabetes 2.83 1.54-5.20 <0.001 
Psychiatric 0.17 0.50-2.76 0.72 
Table 2: Univariate analysis assessing the relationship between various clinical factors and 
perioperative complications.  Data from Tetreault et al. 2016.22 
 
Clinical Predictor Relative Risk 95% CI p Value 
Age 0.918 0.881-0.955 <0.0001 
Comorbidities 0.948 0.859-1.046 0.285 
Comorbidity score 0.966 0.935-0.998 0.035 
Cardiovascular 0.894 0.808-0.989 0.029 
Endocrine 0.879 0.760-1.016 0.080 
Psychiatric 1.058 0.929-1.206 0.397 
Table 3: Univariate analyses evaluating the association between various clinical predictors and 
achieving an MCID on the mJOA scale at 2 years following surgery.  Data from Tetreault et al. 
2016.9 
 
Variable Good Outcome Poor Outcome p Value 
Preoperative    
JOA score 10.6 0.7 0.075 
HbA1c level (%) 6.8 7.2 0.0165 
Post-operative    
JOA score 15.2 11.2 <0.0001 
Recovery rate of 
JOA score 
73.8 22.3 <0.0001 
Table 4: HbA1c levels are correlated with outcomes following surgery for DCM in diabetic 
patients; poor outcome defined as recovery rate of less than 50%.  Data from Machino et al 
2014.16 
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